Kaley Wilson
Chief Executive Officer at Sitka Biopharma, Inc.
Profile
Kaley Wilson is currently the Chief Executive Officer at Sitka Biopharma, Inc. and a Director at Microbion Corp., Quark Venture, Inc., and Crohn's & Colitis Canada.
Previously, he was the Chief Executive Officer at ARTMS, Inc. from 2018 to 2019.
He holds a doctorate degree from the University of British Columbia.
Kaley Wilson active positions
| Companies | Position | Start |
|---|---|---|
Microbion Corp.
 Microbion Corp. Pharmaceuticals: MajorHealth Technology Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT. | Director/Board Member | - |
Sitka Biopharma, Inc.
 Sitka Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sitka Biopharma, Inc. develops novel polymer platform technology that improves drug absorption for cancer treatments. The company was founded by Michael Parr in 2013 and is headquartered in Vancouver, the United Kingdom. | Chief Executive Officer | - |
Quark Venture, Inc.
 Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc (Quark) is a venture capital investment firm founded in 2015 and headquartered in Vancouver, Canada. | Private Equity Investor | 2016-09-30 |
| Crohn?s & Colitis Canada | Director/Board Member | 2021-04-30 |
Former positions of Kaley Wilson
| Companies | Position | End |
|---|---|---|
ARTMS, Inc.
 ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | Chief Executive Officer | 2019-09-09 |
Training of Kaley Wilson
| University of British Columbia | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | Health Technology |
Microbion Corp.
Microbion Corp. Pharmaceuticals: MajorHealth Technology Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT. | Health Technology |
Sitka Biopharma, Inc.
Sitka Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sitka Biopharma, Inc. develops novel polymer platform technology that improves drug absorption for cancer treatments. The company was founded by Michael Parr in 2013 and is headquartered in Vancouver, the United Kingdom. | Health Technology |
Quark Venture, Inc.
Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc (Quark) is a venture capital investment firm founded in 2015 and headquartered in Vancouver, Canada. | Finance |
| Crohn?s & Colitis Canada |
- Stock Market
- Insiders
- Kaley Wilson
